Literature DB >> 26067395

The utility of preoperative six-minute-walk distance in lung transplantation.

Anthony W Castleberry1,2, Brian R Englum1,3, Laurie D Snyder4, Mathias Worni1,5, Asishana A Osho6, Brian C Gulack1,3, Scott M Palmer4, R Duane Davis1,2, Matthew G Hartwig1,2.   

Abstract

RATIONALE: The use of 6-minute-walk distance (6MWD) as an indicator of exercise capacity to predict postoperative survival in lung transplantation has not previously been well studied.
OBJECTIVES: To evaluate the association between 6MWD and postoperative survival following lung transplantation.
METHODS: Adult, first time, lung-only transplantations per the United Network for Organ Sharing database from May 2005 to December 2011 were analyzed. Kaplan-Meier methods and Cox proportional hazards modeling were used to determine the association between preoperative 6MWD and post-transplant survival after adjusting for potential confounders. A receiver operating characteristic curve was used to determine the 6MWD value that provided maximal separation in 1-year mortality. A subanalysis was performed to assess the association between 6MWD and post-transplant survival by disease category.
MEASUREMENTS AND MAIN RESULTS: A total of 9,526 patients were included for analysis. The median 6MWD was 787 ft (25th-75th percentiles = 450-1,082 ft). Increasing 6MWD was associated with significantly lower overall hazard of death (P < 0.001). Continuous increase in walk distance through 1,200-1,400 ft conferred an incremental survival advantage. Although 6MWD strongly correlated with survival, the impact of a single dichotomous value to predict outcomes was limited. All disease categories demonstrated significantly longer survival with increasing 6MWD (P ≤ 0.009) except pulmonary vascular disease (P = 0.74); however, the low volume in this category (n = 312; 3.3%) may limit the ability to detect an association.
CONCLUSIONS: 6MWD is significantly associated with post-transplant survival and is best incorporated into transplant evaluations on a continuous basis given limited ability of a single, dichotomous value to predict outcomes.

Entities:  

Keywords:  exercise tolerance; lung transplantation; patient outcome assessment

Mesh:

Year:  2015        PMID: 26067395      PMCID: PMC5447300          DOI: 10.1164/rccm.201409-1698OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  35 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011.

Authors:  Jason D Christie; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2011-10       Impact factor: 10.247

Review 3.  Cardiopulmonary exercise testing: a review of methods and applications in surgical patients.

Authors:  Zoe A Ridgway; Simon J Howell
Journal:  Eur J Anaesthesiol       Date:  2010-10       Impact factor: 4.330

4.  Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly.

Authors:  P Older; A Hall; R Hader
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

5.  Cardiopulmonary exercise tests and lung cancer surgical outcome.

Authors:  Thida Win; Arlene Jackson; Linda Sharples; Ashley M Groves; Francis C Wells; Andrew J Ritchie; Clare M Laroche
Journal:  Chest       Date:  2005-04       Impact factor: 9.410

6.  Preoperative shuttle walking testing and outcome after oesophagogastrectomy.

Authors:  P Murray; P Whiting; S P Hutchinson; R Ackroyd; C J Stoddard; C Billings
Journal:  Br J Anaesth       Date:  2007-10-24       Impact factor: 9.166

7.  A comparative analysis of bronchial stricture after lung transplantation in recipients with and without early acute rejection.

Authors:  Anthony W Castleberry; Mathias Worni; Maragatha Kuchibhatla; Shu S Lin; Laurie D Snyder; Scott L Shofer; Scott M Palmer; Ricardo Pietrobon; R Duane Davis; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2013-07-18       Impact factor: 4.330

8.  Baseline 6-min walk distance predicts survival in lung transplant candidates.

Authors:  T Martinu; M A Babyak; C F O'Connell; R M Carney; E P Trulock; R D Davis; J A Blumenthal; S M Palmer
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

9.  Reference equations for the six-minute walk in healthy adults.

Authors:  P L Enright; D L Sherrill
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

10.  Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma.

Authors:  K S Chok; K K Ng; R T Poon; C M Lo; S T Fan
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

View more
  17 in total

Review 1.  Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.

Authors:  Brandi A Bottiger; Alina Nicoara; Laurie D Snyder; Paul E Wischmeyer; Jacob N Schroder; Chetan B Patel; Mani A Daneshmand; Robert N Sladen; Kamrouz Ghadimi
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-09       Impact factor: 2.628

Review 2.  Frailty in Pulmonary and Critical Care Medicine.

Authors:  Jonathan P Singer; David J Lederer; Matthew R Baldwin
Journal:  Ann Am Thorac Soc       Date:  2016-08

3.  Frailty phenotypes and mortality after lung transplantation: A prospective cohort study.

Authors:  Jonathan P Singer; Joshua M Diamond; Michaela R Anderson; Patricia P Katz; Ken Covinsky; Michelle Oyster; Tatiana Blue; Allison Soong; Laurel Kalman; Pavan Shrestha; Selim M Arcasoy; John R Greenland; Lori Shah; Jasleen Kukreja; Nancy P Blumenthal; Imaani Easthausen; Jeffrey A Golden; Amika McBurnie; Ed Cantu; Joshua Sonett; Steven Hays; Hilary Robbins; Kashif Raza; Matthew Bacchetta; Rupal J Shah; Frank D'Ovidio; Aida Venado; Jason D Christie; David J Lederer
Journal:  Am J Transplant       Date:  2018-05-14       Impact factor: 8.086

Review 4.  Lung transplantation at Duke.

Authors:  Alice L Gray; Michael S Mulvihill; Matthew G Hartwig
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

5.  Pre-transplant weight loss and clinical outcomes after lung transplantation.

Authors:  Emily Siu Clausen; Courtney Frankel; Scott M Palmer; Laurie D Snyder; Patrick J Smith
Journal:  J Heart Lung Transplant       Date:  2018-07-29       Impact factor: 10.247

6.  A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: A pilot study.

Authors:  Jonathan P Singer; Allison Soong; Allan Bruun; Ayana Bracha; Greg Chin; Steven R Hays; Jasleen Kukreja; Julia Rigler; Jeff A Golden; John R Greenland; Chris Garvey
Journal:  Clin Transplant       Date:  2018-06-20       Impact factor: 2.863

7.  A 1-Month Physical Therapy-Based Outpatient Program for Adults Awaiting Lung Transplantation: A Retrospective Analysis of Exercise Capacity, Symptoms, and Quality of Life.

Authors:  Rebecca Byrd; Patrick Smith; Omar Mohamedaly; Laurie D Snyder; Amy M Pastva
Journal:  Cardiopulm Phys Ther J       Date:  2019-04

Review 8.  Older candidates for kidney transplantation: Who to refer and what to expect?

Authors:  Beatrice P Concepcion; Rachel C Forbes; Heidi M Schaefer
Journal:  World J Transplant       Date:  2016-12-24

9.  Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.

Authors:  Isabelle Delanote; Wim A Wuyts; Jonas Yserbyt; Eric K Verbeken; Geert M Verleden; Robin Vos
Journal:  BMC Pulm Med       Date:  2016-11-18       Impact factor: 3.317

10.  Six-minute walk distance in healthy young adults.

Authors:  Stephen J Halliday; Li Wang; Chang Yu; Brian P Vickers; John H Newman; Richard D Fremont; Luis E Huerta; Evan L Brittain; Anna R Hemnes
Journal:  Respir Med       Date:  2020-03-19       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.